Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 06, 2025 09:30 ET | Source: Genmab A/S

Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)

Media ReleaseCOPENHAGEN, Denmark; December 6, 2025 New two- and three-year EPCORE® NHL-2 follow-up data evaluating epcoritamab in combination with standard of care regimens demonstrate remission in...
December 06, 2025 09:25 ET | Source: Bragar Eagel & Squire

BLUE OWL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Blue Owl Capital, Inc. and Encourages Investors to Contact the Firm

The complaint alleges Blue Owl hid BDC-redemption pressure, liquidity issues, and likely redemption limits, making its positive statements misleading.
December 06, 2025 09:14 ET | Source: Bragar Eagel & Squire

CEPTON URGENT ALERT: Bragar Eagel & Squire, P.C. Reminds Cepton Stockholders of Upcoming December 8th Lead Plaintiff Deadline

The complaint alleges Cepton hid a higher bid, failed to evaluate or disclose it, depriving shareholders of a fair choice and making statements misleading.
December 06, 2025 09:10 ET | Source: SNS Insider pvt ltd

Peptide Therapeutics Market Size to Reach USD 82.19 Billion by 2032; Surging Requirements for Targeted Medicines in Oncology Augment Market Expansion - SNS Insider

Technological advancements in peptide synthesis, expanding R&D pipelines, and strong U.S. market leadership accelerate sector growth at a CAGR of 7.51%.
December 06, 2025 09:05 ET | Source: Bragar Eagel & Squire

MAREX URGENT DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges Marex Stockholders to Contact the Firm Before December 8th Deadline

The complaint alleges Marex sold OTC instruments to itself, had major financial inconsistencies, issued unreliable financials, and misled investors.
December 06, 2025 08:53 ET | Source: Bragar Eagel & Squire

ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds aTyr Investors to Contact the Firm Before December 8th Regarding Their Rights

The complaint alleges defendants overstated Efzofitimod’s efficacy, hid steroid-taper issues, and inflated aTyr’s stock through these misstatements.
December 06, 2025 08:45 ET | Source: SNS Insider pvt ltd

CBD Nutraceuticals Market Projected to Reach USD 39.06 Billion by 2032 at 16.38% CAGR – SNS Insider

The Global CBD Nutraceuticals Market Growth Is Driven by the Rising Demand for Natural Wellness Products and Expanding Legalization of Hemp-derived CBD.
December 06, 2025 08:34 ET | Source: The Rosen Law Firm PA

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages StubHub Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STUB

NEW YORK, Dec. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of StubHub Holdings, Inc. (NYSE: STUB) pursuant and/or...
December 06, 2025 08:30 ET | Source: Adaptive Biotechnologies

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

Adaptive announces deep interventional use of clonoSEQ across abstracts at ASH
December 06, 2025 08:30 ET | Source: SNS Insider pvt ltd

Tele-intensive Care Unit Market Size to Reach USD 11.96 Billion by 2032; Growing Advancements in Technology to Propel Market Growth Globally – SNS Insider

Growing adoption of AI enabled remote monitoring and strong demand for critical care efficiency propel tele-intensive care unit market worldwide.